Skip to content
Oncology Research Hub

Research area

Pancreatic Cancer clinical trials

Studies in pancreatic cancer examine investigational medications, combinations of therapies, and methods of early detection. If you are looking for yourself or for someone in your family, Oncology Research Hub can help you find out whether a study may be a fit.

Updated

Call (888) 343-1186
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Pancreatic cancer studies in numbers

pancreatic cancer studies recruiting in the U.S.
380
states with a study site
51
studies that accept healthy volunteers
29

Source: ClinicalTrials.gov. Data processed .

Find pancreatic cancer studies by state

These states have the most studies recruiting right now.

Pancreatic cancer studies recruiting now

As of November 16, 2026, 380 pancreatic cancer studies are recruiting participants in the United States, according to ClinicalTrials.gov. This is what they have in common.

What they test

  • medications228
  • other approaches55
  • procedures54
  • biologics such as vaccines or antibodies32
  • devices31

A study can test more than one.

Main purpose

  • treating a condition233
  • diagnosis26
  • supportive care13
  • how care is delivered9

Phase

  • Early Phase 17
  • Phase 196
  • Phase 1/263
  • Phase 257
  • Phase 2/35
  • Phase 317
  • Phase 42
  • No phase53
  • Observational80

Studies of devices and behavioral approaches have no phase.

Who runs them

  • university, hospital or other212
  • industry151
  • government17

Who they enroll

  • adults (18 to 64)378
  • older adults (65 and over)375
  • children (under 18)22

29 also accept healthy volunteers.

These counts come from each study's public record and change as studies open and close. Browse every location to see what is recruiting near you.

Source: ClinicalTrials.gov. Data processed . Each bar shows a count as a share of all 380 studies.

Recently updated pancreatic cancer studies

The 6 studies whose public records changed most recently, with some of the places each is recruiting. Select a study to read its full record on ClinicalTrials.gov.

  1. GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer

    • Early Phase 1
    • Ages 18 to 99
    • All sexes
    Sponsor
    University of Arizona
    Recruiting in
    Tucson, AZ
    Registry record
    NCT07627191 · updated
  2. Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

    • Phase 2
    • Ages 12 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Ann Arbor, MI · Baltimore, MD · Bethesda, MD · and 7 more U.S. locations
    Registry record
    NCT04924075 · updated
  3. A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Global Development, Inc.
    Recruiting in
    Boston, MA · Durham, NC · New York, NY
    Registry record
    NCT07024615 · updated
  4. A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Incyte Corporation
    Recruiting in
    Anchorage, AK · Ann Arbor, MI · Atlanta, GA · and 43 more U.S. locations
    Registry record
    NCT07522073 · updated
  5. A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Verastem, Inc.
    Recruiting in
    Ann Arbor, MI · Baltimore, MD · Boston, MA · and 21 more U.S. locations
    Registry record
    NCT07644559 · updated
  6. Cancer in Inherited Bone Marrow Failure Syndromes

    • Observational
    • From 1 day, up to 100 years
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Bethesda, MD · Rockville, MD
    Registry record
    NCT00027274 · updated

Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in the United States on ClinicalTrials.gov.

What pancreatic cancer studies look at

Researchers studying pancreatic cancer are testing investigational medications, combinations of therapies, and early-detection methods. Each study sets out to answer one specific question. Because of that, what you would be asked to do varies from one study to the next, and the same holds if you are reading on behalf of a relative.

Everything tested in a pancreatic cancer study is investigational. Researchers are still learning how well it works and what risks it carries. That is why the study exists.

Who may be able to take part

Each cancer study sets its own requirements. Age, health history, current medications, and how a condition affects you can all be among them. Some studies also enroll people who do not have the condition.

Working out eligibility is not something you or your family have to do alone. The study team checks it at a screening visit. See how eligibility and screening work.

What taking part usually involves

  1. A first conversation

    The first conversation is with a coordinator. They describe the cancer study in general terms and answer your questions before anything else happens.

  2. Informed consent

    You receive the full details from the study team in writing, known risks included. Whether to agree is your decision.

  3. Screening

    Screening uses health questions and tests to show whether the cancer study is suitable for you. Some people who are screened do not go on to take part.

  4. Study visits

    Joining means attending scheduled visits, which let the team follow your health. Leaving the study is possible at any time.

Questions about pancreatic cancer studies

Do I need a diagnosis to join a study about pancreatic cancer?

That varies by study. A confirmed diagnosis is required for some, while others assess you during screening. You will hear from the study team which applies to you.

Would I have to change the care I receive now?

Your current care should not be changed on your own. Some studies allow it to continue and others do not. The study doctor goes over this with you, and before you decide you can discuss it with your own doctor.

Is there a cost to take part?

There is generally no cost to participants for study visits, study tests, and the study medication. Read more about costs.

Ask about pancreatic cancer studies

A coordinator will contact you once you share a few details. Asking commits you to nothing, whether you are asking for yourself or for someone you care for.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Independent information

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 343-1186

or send a short form

How should we reach you?

Call